Trial site

University Hospitals Birmingham

Birmingham, B15 2TH, United KingdomNot linked to an institution yet

11running trials
2closed trials

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions: Childhood cancers2 trials
Atrial fibrillation1 trial
Colorectal cancer1 trial
Coronary artery disease1 trial
Cystic fibrosis1 trial
Cytomegalovirus infection1 trial
Hearing loss1 trial
High blood pressure1 trial
Hodgkin lymphoma1 trial
Liver and biliary tract cancer1 trial
Myasthenia gravis1 trial
Parkinson disease1 trial
and 1 more
Phase: Phase 1/22 trials
Phase 22 trials
Phase 32 trials
Phase 42 trials
Phase 2/31 trial
Status: Recruiting6 trials
Not yet recruiting3 trials
Active, not recruiting2 trials
Completed2 trials
Lead sponsor: University College, London2 trials
University of Birmingham2 trials
Bristol-Myers Squibb1 trial
CRISPR Therapeutics AG1 trial
Fondazione Ricerca e Innovazione Cardiovascolare ETS1 trial
and 6 more

Running trials

Not yet recruiting
First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant
NCT07032038· Phase 1/2· Rinri Therapeutics· Source
Contact: Peter Monksfield
Recruiting
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
NCT07758634· Phase 1/2· CRISPR Therapeutics AG· Source
Contact: Clinical Trials
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357· Phase 2/3· Bristol-Myers Squibb· Source
Contact: Victoria Kunene, Site 0540
Recruiting
HOPE Against Cancer Recurrence in HCC
NCT06717919· Phase 4· Philipp Dutkowski· Source
Contact: Rebeca Sanabria Mateos, Dr.
Recruiting
Ambroxol to Slow Progression in Parkinson Disease
NCT05778617· Phase 3· University College, London· Source
Contact: Ben Wright
Recruiting
Vitaccess Real MG Registry
NCT06064461· Vitaccess Ltd· Source
Contact: Saiju Jacob
Active, not recruiting
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
NCT06237335· Phase 2· ReCode Therapeutics· Source
Recruiting
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT04685616· Phase 3· University College, London· Source
Contact: Lindsay George
Active, not recruiting
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291· Fondazione Ricerca e Innovazione Cardiovascolare ETS· Source
Recruiting
Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
NCT04700826· Phase 4· University of Birmingham· Source
Contact: Minnie Ventura
Recruiting
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
NCT02848274· Stanford University· Source
Contact: Julia Scarisbrick

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Childhood cancers2 recruiting
Atrial fibrillation1 recruiting
Colorectal cancer1 recruiting
Hearing loss1 recruiting
High blood pressure1 recruiting
Hodgkin lymphoma1 recruiting
Liver and biliary tract cancer1 recruiting
Myasthenia gravis1 recruiting
Parkinson disease1 recruiting
Stroke1 recruiting

Closed trials

Completed
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection
NCT06615921· Takeda· Source
Completed
Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome
NCT03717909· Phase 2· University of Birmingham· Source

Site data: ClinicalTrials.govUpdated 13 Nov 2026

Report an error